Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten - Swissmedic Key 61317003 Registration Holder Mepha Pharma AG Name Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten Date of registration 24.02.2011 Original/Generic Generic Introduction of Sequence 24.02.2011 ATC-Classification Ibandronic Acid (M05BA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.99. Show package size Index Therapeuticus (Swissmedic) 07.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 14.43 Limitation Yes Limitation text
Deductible 10 % Consumer price 32.30 Feedback FB Daily cost GTIN 7680613170036 Medication Code Synthetika Pharmacode 7558082 Disponibility ●
Composition acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Ibandronic Acid 150 mg
BAG: Active Agent Dose Ibandronic Acid 150 mg
Inactive agents Dose additional_information Acidum Stearicum Cellulosum Microcristallinum Crospovidonum E 171 Überzug Hypromellosum Macrogol 400 Polysorbatum 80 Povidone Pro Compresso Obducto Silica Colloidalis Anhydrica
Source Data was imported : 03.02.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
